Effects of a combined treatment with tamoxifen and estrogen receptor β agonists on human breast cancer cell lines
- 2 August 2013
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 289 (1) , 163-171
Abstract
Coexpression of estrogen receptors (ER) α and β is present in about half of all breast cancer cases. Whereas ERα is a well-established target for endocrine therapy with the selective estrogen receptor modulator tamoxifen, the applicability of ERβ as target in breast cancer therapy is unclear. In this study, we examined the effects of two synthetic ERβ agonists alone and in combination with tamoxifen on ERα/β-positive breast cancer cells.Keywords
This publication has 26 references indexed in Scilit:
- Single-cell dissection of transcriptional heterogeneity in human colon tumorsNature Biotechnology, 2011
- GeneMANIA Cytoscape plugin: fast gene function predictions on the desktopBioinformatics, 2010
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene functionNucleic Acids Research, 2010
- A human functional protein interaction network and its application to cancer data analysisGenome Biology, 2010
- Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors α and β: Mutual Restriction and Competitive Site SelectionMolecular Endocrinology, 2010
- Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cellsBreast Cancer Research and Treatment, 2009
- Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptorEndocrine-Related Cancer, 2008
- GeneMANIA: a real-time multiple association network integration algorithm for predicting gene functionGenome Biology, 2008
- Effects of exon-deleted estrogen receptor β transcript variants on growth, apoptosis and gene expression of human breast cancer cell linesBreast Cancer Research and Treatment, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001